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Abstract
Breast cancer accounts for 30% of all cancer. Metastasis is the primary cause of death among
breast cancer patients. Additionally, current molecular profiling methods such as Oncotype DX,
which are expensive and not widely available at all clinical facilities, only determine the risk of
recurrence after treatment. Therefore, there are no current method capable of identifying
metastatic patients in advance. As a result, there is an unmet clinical need to develop a costeffective prognostic to differentiate between indolent and aggressive breast tumors. In this study,
we implemented diffuse reflectance spectroscopy (DRS) system to evaluate functional changes
in tumor xenografts originated from four breast cancer cell lines with variable metastatic
potential. The murine mammary cell lines 4T1, 4T07, 168FARN, and 67NR were injected into
the flanks of mice to grow tumor xenografts. In addition, we used CRISPR/Cas-9 to delete
TWIST- a gene known to promote tumor metastasis - and generate an indolent version of 4T1
(4T1-TWIST KO) that was also grown as xenografts. We collected optical data from these
tumors bearing animals and using a look-up table inverse model, we determined vascular oxygen
saturation (SO2), total hemoglobin concentration (cHb), and tissue light scattering at four
different tumor volumes. Our preliminary data shows functional differences between indolent
and aggressive tumors that can be further investigated in human cell line and patient-derived
tumors.
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Introduction
Breast cancer is a frequent malignancy with high mortality due to the effects generated by the
primary tumor and its high capacity to produce distant metastases [1]. 30% of breast cancer
patients are diagnosed at an early stage of the disease, and they are likely to experience
recurrence of the disease with distant metastasis, which accounts for 90% of deaths among breast
cancer [2]. Clinically, doctors rely on anatomical markers, such as tumor stage and lymph node
status for decisions related to neoadjuvant chemotherapy, and current methods to assess
chemotherapy benefits such as Oncotype DX, based on molecular profiling, are only capable of
determining risk of recurrence after treatment [3]. Additionally, Oncotype DX is not available at
all clinical facilities, it is highly expensive, and its application is limited by tumor size and
established tumor receptors [3,4]. So, there is still an unmet clinical need to differentiate between
indolent and aggressive disease.
As a result, the development of a cost-effective prognostic tool that can be implemented to
evaluate metastatic potential could significantly aid to the treatment of breast cancer patients [5].
So, it is desirable to identify differences in tumor biology and physiology that come from the
metastatic nature of the primary tumor. In this context, optical spectroscopy techniques are
highly attractive due to their capacity to provide insights on tumor vascularity, tissue scattering,
and oxygenation.
To illustrate, Diffuse reflectance spectroscopy (DRS), which is a widely used optical
spectroscopy technique, allows the characterization of the tumor microenvironment through light
that has undergone multiple scattering events within a sample of interest [6]. DRS have been
proven to assess tumor vascularity and oxygenation because the spectra diffusely reflected from
tissue, depends on the scattering and absorption properties of the tumor [7]. From the collected
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light, the reflectance spectrum can be generated, and tissue scattering, hemoglobin concentration
(cHb), and oxygen saturation (sO2) can be determine.
In this study, we implemented a diffuse reflectance spectroscopy (DRS) system to evaluate
functional changes in tumor xenografts that originated from five breast cancer cell lines with
variable metastatic potential. The isogenic murine mammary cell lines, 4T1, 4T07, 168FARN,
and 67NR (in descending metastatic potential), were derived from a breast tumor growing in a
Balb/c mouse [8]. All of the murine mammary cell lines are capable of primary tumor formation;
however, 4T1, 4T07, and 168FARN are the only ones capable of intravasation. 4T1 and 4T07
can extravasate, and only 4T1 is capable of metastatic growth. Studies on these cell lines have
shown that TWIST plays a significant role in their metastatic potential [9,10]. TWIST,
considered a master regulator of metastasis, was profoundly expressed in not only this family of
isogenic cell lines but also in several invasive and metastatic human tumors [10]. So, the ability
to knock out the TWIST gene can provide information regarding differences between indolent
and aggressive breast tumors. Therefore, the aim of our study was to use Optical Spectroscopy to
determine functional differences in the primary tumor between metastatic and non-metastatic cell
lines.
Materials and Methods
Cell Culture and Tumor Xenograft
The cell lines, 4T1, 4T07, 67NR, and 168FARN, derived from a spontaneous breast tumor
growing in a Balb/c mouse, were provided by Dr. Fred Miller (Karmanos Cancer Institute).
CRISPR/Cas-9 was used to generate an indolent version of 4T1 by knocking out the TWIST
gene (4T1-TWIST KO). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
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with the addition of 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 1% (v/v)
nonessential amino acids, and 1% (v/v) penicillin-streptomycin. The cells were cultured in a
humidified incubator set to 5% CO2 and 37°C and passaged when they reached approximately
80% confluence. Cells were used within the first 10 passages for all experiments. The five
murine mammary adenocarcinoma cells were injected into the flanks of 10 Balb/c mice each to
grow xenografts (n=50). Tumors xenograft were formed by injecting 2 million cells suspended
in 1:1 Matrigel.
CRISPR/Cas9 for the deletion of TWIST gene
The sgRNA guide tool provided by the Zhang laboratory (MIT, Cambridge, MA) was used to
identify sgRNA to aim at the TWIST gene. The 20-base pair sgRNA was cloned into
pCasGuide-EF1a-GFP plasmids through the services of OriGene (Rockville, MD). E. Coli
bacteria were used to expand the plasmid, which was isolated utilizing the QIAGEN Plasmid
Maxi Kit. Plasmid transfection was achieved by seeding 4T1 cells in a 6-well plate at a
concentration of one million cells/well for an incubation time of 24 for hours. 10 μg of plasmid
were added to Lipofectamine 3000 to be added to the 4T1 cells. After 24 to 48 hours, a Nikon
TiE fluorescence microscope workstation with a ColSnap HQ2 camera was used to detect the
signals exhibiting green fluorescent proteins (GFP), indicating cell transfection. A PBS solution
was used to suspend the transfected 4T1 cells at a concentration of two million cells per mL,
which were subsequently filtered into a FACS tube with a 50 μm filter. The cells were sorted
through the FACS Aria III System (BD Biosciences, San Jose, CA). The 5% percent of
transfected cells with the highest GFP expression were classified as cells with the greatest
CRISPR / Cas9 plasmid concentration. The classified cells were incubated for 7 to 14 days and
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the formed cell colonies were cloned into 13 clones to produce a cell population, having the least
TWIST expression.
Diffuse Reflectance Spectroscopy
The implemented DRS setup consisted of a tungsten halogen lamp (HL-2000, Ocean Optics;
Dunedin, Florida) supplying a fiber optic spectrometer for data acquisition (Flame, Ocean
Optics; Dunedin, Florida), and a fiber-optic probe (dia. = 200 μm, NA = 0.22; FiberTechOptica,
Ontario, Canada) with source-detector separation of 2.25 mm (figure 1A). The diffusely reflected
light was collected by the five peripheral fibers of the fiber optic probe, which surround four
source central fibers (figure 1B). DRS spectra acquisition were performed at four different tumor
volumes, 50, 100, 150, and 200 mm3, for three specific murine mammary cell lines, 4T1, 4T1TWIST KO, and 67NR. DRS spectra acquisition for 4T07 and 168FARN were performed at 200
mm3.
Quantification of tissue optical properties and statistical analysis
Using an empirical lookup table-based inverse model, we determined scattering, total
hemoglobin concentration (cHb), and the vascular oxygen saturation (sO2). A nested, two-way
analysis of variance (ANOVA) was implemented to determine statistical significant differences
in tissue scattering, hemoglobin concentration and vascular oxygenation across the five murine
mammary cell lines, 4T1, 4T1, 4T07, 67NR, 168FARN, and 4T1-TWIST KO.
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Figure 1. A. Experimental setup of diffuse optical spectroscopy consisting of an optical fiber
probe delivering light supplied from a halogen lamp and transferring the reflected light from
tissue to a spectrometer. B. Representation of the probe common end with a source detention
separation of 2.25mm depicting the five peripheral fibers and the four source central fibers.

Results and Discussion
Representative in vivo reflectance, absorption and scattering
Representative DRS spectra of the five murine breast cancer cell lines at 200 mm3 are shown on
figure 2A. The solid black line indicates the in vivo measurements, and the solid red lines the
LUT model fit. The DRS spectra showed that 4T07 and 168FARN presents have more
pronounced hemoglobin band, which is the section of the curve between 540 and 580 nm,
indicating high oxygen saturation. In comparison with 4T1 and 67NR, which have a flatter or
less pronounce hemoglobin band, indicating lower oxygen saturation. It is also worth noting that
4T1-TWIST KO have a more pronounced hemoglobin band than 4T1. The corresponding
dependent absorption coefficients are represented in figure 2B. 4T07, 168FARN, and 4T1TWIST KO, shown in the absorption plot as a function of wavelength, present the two distinctive
peaks between 540 and 580 nm characteristic of the hemoglobin absorption profile. 67NR has
the highest absorption levels but with low oxygenation and 4T1 displayed a lower magnitude of
the absorption coefficient in comparison to the 4T1-TWIST KO cell line. As shown in figure 2C,
8

4T07 and 168FARN present the highest scattering coefficients, while the 67NR tumor
population presents the lowest.

Figure 2. A. Diffuse reflectance spectra (black line) and the corresponding experimental-fit (red
line) from representative animals from different groups. B. Absorption coefficient as a function
of wavelength for the different tumor populations C. Scattering coefficient as a function of
wavelength for the different tumor populations.
Significant differences in hemoglobin concentration and LIGHT scattering among the studied
cell lines at 200 mm3

Figure 3 A. Significant differences in total hemoglobin content between 4T1 and 4T07 xenografts
and between 4T1 and 67NR at 200 mm3. B. Vascular oxygen saturation with no significant
differences between the different tumor populations. C. Significant Differences were detected
between the highly metastatic 4T1 cell line and the 4T07 tumor population and between 4T07
and 4T1- TWIST KO at 200 mm3.
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Scattering is significantly greater in the metastatic 4T1 tumors compared with the non-metastatic
67NR tumors

Figure 4 A. Tissue Scattering as a function of tumor growth reveal there are significant
functional differences between the metastatic cell line 4T1 and the non-metastatic cell line
67NR. B. Vascular oxygen saturation decreases as tumor volume increases shifting lower and
lower in the non-metastatic cell lines 67NR and 4T1-TKO.
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There were significant differences in hemoglobin concentration and tissue scattering among the
studied cell lines at 200 mm3. As shown in figure 3A, total hemoglobin concentration was shown
to be different between the 4T1 and the 4T07 tumor populations with statistically significant
differences between the two groups (p=0.08). Similarly, there were statistically significant
differences between 4T1 and 67NR on hemoglobin concentration (p=0.009). It is also noticeable
that total hemoglobin concentration has a slight increase as metastatic potential decreases with
4T1 having the lowest levels and 67NR the highest.
Tissue scattering is significantly greater in the metastatic 4T1 tumors compared with the nonmetastatic 67NR tumors (figure 4A). Statistical analysis of the scattering intensity data showed a
significant difference at 100 mm3 (p<0.001), and at 150 mm3 (p=0.005). It is noticeable that
there is a decrease of tissue scattering as tumor volume increases on the 67NR tumor population.
No statistically significant interactions on tissue scattering were found between the 4T1 and the
4T1-TWST KO tumor population across the four tumor volumes. The significant difference
between 4T1 and 67NR presents the question regarding the source of scattering. Even though we
knock down twist in the primary tumor, tissue scattering essentially stays the same between 4T1
and 4T1-TWIST KO and giving that DRS is highly sensitive to collagen, future studies on the
primary tumor of the non-metastatic 67NR and the metastatic 4T1 cell lines are required to
explain such phenomenon. Additionally, as shown in figure 3C, there were significant
differences in tissue scattering between the 4T1 and the 4T07 tumors, between 168FARN and
4T1-TWIST KO tumors, and between 4T07 and 4T1-TWIST KO tumors at 200 mm3.
Regarding vascular oxygen saturation for each cell line, 4T1,67NR and 4T1-TWIST KO, is
represented in figure 4B at the four different tumor volumes. A downtrend on sO2 is observed in
the 67NR and the 4T1-TWIST KO tumors. TWIST deletion showed to demote sO2 on the 4T1
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cell line. However, there were no significant differences in sO2 between 4T1 and 4T1-TWIST
KO (p>0.05).
Conclusion
Metastatic spread is the primary cause of death among breast cancer patients. Clinically, doctors
rely on anatomical markers or highly expensive molecular profiling methods for early detection
of metastatic patients. However, a precise classification of metastatic from non-metastatic tumors
continues to be a challenge. With non-invasive techniques such as diffuse reflectance
spectroscopy, understanding of functional differences can be achieved to differentiate indolent
from aggressive disease. In this study, we have shown that diffuse reflectance spectroscopy is
sensitive to differences in hemoglobin content between metastatic 4T1 and non-metastatic 67NR
tumors. Additionally, our results indicate significant differences in scattering between metastatic
(4T1) and non-metastatic tumors (67NR), and a downtrend of vascular oxygen saturation in nonmetastatic tumors as tumor volume increases. The preliminary results of this study demonstrate
the potential of diffuse reflectance spectroscopy on detecting functional biomarkers that can be
implemented in sorting metastatic and non-metastatic tumors.
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